Land: Singapore
Sprog: engelsk
Kilde: HSA (Health Sciences Authority)
MIVACURIUM CHLORIDE
DCH AURIGA SINGAPORE
M03AC10
10 mg/5 ml
INJECTION
MIVACURIUM CHLORIDE 10 mg/5 ml
INTRAVENOUS
Prescription Only
GLAXOSMITHKLINE MANUFACTURING SPA
ACTIVE
1994-01-26
CONFIDENTIAL MIVACRON™ MIVACURIUM CHLORIDE QUALITATIVE AND QUANTITATIVE COMPOSITION _INJECTION: _ Sterile solution containing 2 mg mivacurium_ _per ml as mivacurium chloride, without an antimicrobial preservative, supplied in ampoules. PHARMACEUTICAL FORM Solution for injection or infusion. CLINICAL PARTICULARS INDICATIONS_ _ _MIVACRON_ is a highly selective, short-acting, non-depolarising neuromuscular blocking agent with a fast recovery profile. _MIVACRON_ is used as an adjunct to general anaesthesia to relax skeletal muscles and to facilitate tracheal intubation and mechanical ventilation. The injection formulation contains no antimicrobial preservative and is intended for single patient use. DOSAGE AND ADMINISTRATION In common with all neuromuscular blocking agents, monitoring of neuromuscular function is recommended during the use of_ MIVACRON_ in order to individualise dosage requirements. With _MIVACRON_, significant train-of-four fade is not seen during onset. It is often possible to intubate the trachea before complete abolition of the train-of-four response of the adductor pollicis muscle has occurred. POPULATIONS • ADULTS _MIVACRON_ is administered by intravenous (i.v.) injection. The mean dose required to produce 95% suppression of the adductor pollicis single twitch response to ulnar nerve CONFIDENTIAL stimulation (ED95) is 0.07 mg/kg (range 0.06 to 0.09) in adults receiving narcotic anaesthesia. The following dose regimens are recommended for tracheal intubation: I. A dose of 0.2 mg/kg, administered over 30 seconds, produces good to excellent conditions for tracheal intubation within 2.0 to 2.5 minutes. II. A dose of 0.25 mg/kg, administered as a divided dose (0.15 mg/kg followed 30 seconds later by 0.1 mg/kg), produces good to excellent conditions for tracheal intubation within 1.5 t Læs hele dokumentet
MIVACRON Mivacurium chloride QUALITATIVE AND QUANTITATIVE COMPOSITION Injection: Sterile solution containing 2 mg mivacurium per ml as mivacurium chloride, without an antimicrobial preservative, supplied in ampoules. PHARMACEUTICAL FORM Solution for injection or infusion. CLINICAL PARTICULARS Indications MIVACRON is a highly selective, short-acting, non-depolarising neuromuscular blocking agent with a fast recovery profile. MIVACRON is used as an adjunct to general anaesthesia to relax skeletal muscles and to facilitate tracheal intubation and mechanical ventilation. The injection formulation contains no antimicrobial preservative and is intended for single patient use. Dosage and Administration In common with all neuromuscular blocking agents, monitoring of neuromuscular function is recommended during the use of MIVACRON in order to individualise dosage requirements. With MIVACRON , significant train-of-four fade is not seen during onset. It is often possible to intubate the trachea before complete abolition of the train-of- four response of the adductor pollicis muscle has occurred. Populations • Adults MIVACRON is administered by intravenous (i.v.) injection. The mean dose required to produce 95% suppression of the adductor pollicis single twitch response to ulnar nerve stimulation (ED 95 ) is 0.07 mg/kg (range 0.06 to 0.09) in adults receiving narcotic anaesthesia. The following dose regimens are recommended for tracheal intubation: I. A dose of 0.2 mg/kg, administered over 30 seconds, produces good to excellent conditions for tracheal intubation within 2.0 to 2.5 minutes. II. A dose of 0.25 mg/kg, administered as a divided dose (0.15 mg/ kg followed 30 seconds later by 0.1 mg/kg), produces good to excellent conditions for tracheal intubation within 1.5 to 2.0 minutes of completion of administration of the first dose portion. The recommended bolus dose range for healthy adults is 0.07 to 0.25 mg/kg. The duration of neuromuscular block is related to the dose. Doses of 0.07, 0.15, 0.20 and 0.25 mg/kg produce Læs hele dokumentet